{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:43:19Z","timestamp":1782801799969,"version":"3.54.5"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["201405CPP 329455-107837"],"award-info":[{"award-number":["201405CPP 329455-107837"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple options for permanent or long-acting contraception are available, each with adverse effects and benefits. People seeking to end their fertility, and their healthcare providers, need a comprehensive comparison of methods to support their decision-making. Permanent contraceptive methods should be compared with long-acting methods that have similar effectiveness and lower anticipated adverse effects, such as the levonorgestrel-releasing intrauterine contraception (LNG-IUC). We aimed to understand the comparability of options for people seeking to end their fertility, using high-quality studies. We sought studies comparing laparoscopic tubal ligation, hysteroscopic tubal occlusion, bilateral salpingectomy, and insertion of the LNG-IUC, for effectiveness, adverse events, tolerability, patient recovery, non-contraceptive benefits, and healthcare system costs among females in high resource countries seeking to permanently avoid conception.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We followed PRISMA guidelines, searched EMBASE, Pubmed (Medline), Web of Science, and screened retrieved articles to identify additional studies. We extracted data on population, interventions, outcomes, follow-up, health system costs, and study funding source. We used the Newcastle\u2013Ottawa Scale to assess risk of bias and excluded studies with medium\u2013high risk of bias (NOS\u2009&lt;\u20097). Due to considerable heterogeneity, we performed a narrative synthesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our search identified 6,612 articles. RG, BV, BC independently reviewed titles and abstracts for relevance. We reviewed the full text of 154 studies, yielding 34 studies which met inclusion criteria. We excluded 10 studies with medium\u2013high risk of bias, retaining 24 in our synthesis. Most studies compared hysteroscopic tubal occlusion and\/or laparoscopic tubal ligation. Most comparisons reported on effectiveness and adverse events; fewer reported tolerability, patient recovery, non-contraceptive benefits, and\/or healthcare system costs. No comparisons reported accessibility, eligibility, or follow-up required. We found inconclusive evidence comparing the effectiveness of hysteroscopic tubal occlusion to laparoscopic tubal ligation. All studies reported adverse events. All forms of tubal interruption reported a protective effect against cancers. Tolerability appeared greater among tubal ligation patients compared to hysteroscopic tubal occlusion patients. No high-quality studies included the LNG-IUC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Studies are needed to directly compare surgical forms of permanent contraception, such as tubal ligation or removal, with alternative options, such as intrauterine contraception to support decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>PROSPERO [CRD42016038254].<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12978-021-01201-z","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T05:02:59Z","timestamp":1626757379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparing options for females seeking permanent contraception in high resource countries: a systematic review"],"prefix":"10.1186","volume":"18","author":[{"given":"Rebecca","family":"Gormley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4340-7882","authenticated-orcid":false,"given":"Wendy V.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"1201_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/GCO.0000000000000213","volume":"27","author":"E Patil","year":"2015","unstructured":"Patil E, Jensen J. Update on permanent contraception options for women. Curr Opin Obstet Gynecol. 2015;27:465\u201370.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1201_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s13669-018-0253-3","volume":"7","author":"K Alton","year":"2018","unstructured":"Alton K, Jensen J. Update on permanent contraception for women. Curr Obst Gynecol Rep. 2018;7:163\u201371.","journal-title":"Curr Obst Gynecol Rep"},{"key":"1201_CR3","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.ijgo.2015.04.024","volume":"131","author":"R Joshi","year":"2015","unstructured":"Joshi R, Khadilkar S, Patel M. Global trends in use of long-acting reversible and permanent methods of contraception: seeking a balance. Int J Gynaecol Obstet. 2015;131:S60\u20133.","journal-title":"Int J Gynaecol Obstet"},{"key":"1201_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1701-2163(16)34242-6","volume":"31","author":"A Black","year":"2009","unstructured":"Black A, Yang Q, Wu Wen S, Lalonde AB, Guilbert E, Fisher W. Contraceptive use among canadian women of reproductive age: results of a National Survey. J Obstet Gynaecol Can. 2009;31:627\u201340.","journal-title":"J Obstet Gynaecol Can"},{"key":"1201_CR5","first-page":"1","volume":"10","author":"K Daniels","year":"2015","unstructured":"Daniels K, Daugherty J, Jones J, Mosher W. Curent contraceptive use and variation by selected characteristics among women aged 15\u201344: United States, 2011\u20132013. Natl Health Stat Report. 2015;10:1\u201314.","journal-title":"Natl Health Stat Report"},{"key":"1201_CR6","unstructured":"MedEffect Canada. Summary Safety Review - ESSURE Permanent BIrth Control System - Assessing the Risk of Complications and the Potential Need for Device Removal. In: Health Canada, ed., 2016."},{"key":"1201_CR7","unstructured":"FDA. FDA News Release: FDA takes additional action to better understand safety of Essure, inform patients of potential risks. 2016."},{"key":"1201_CR8","unstructured":"Bayer. Essure FAQ. Whippany, NJ: Bayer, 2018 (vol 2019)."},{"key":"1201_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jmig.2006.05.014","volume":"13","author":"M Nichols","year":"2006","unstructured":"Nichols M, Carter JF, Fylstra DL, Childers M. A comparative study of hysteroscopic sterilization performed in-office versus a hospital operating room. J Minim Invasive Gynecol. 2006;13:447\u201350.","journal-title":"J Minim Invasive Gynecol"},{"key":"1201_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1479-828X.2001.tb01311.x","volume":"41","author":"J Kerin","year":"2001","unstructured":"Kerin J, Carignan C, Cher D. The safety and effectiveness of a new hysteroscopic method for permanent birth control: results of the first EssureTM pbc clinical study. Aust N Z J Obstet Gynaecol. 2001;41:364\u201370.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1516\u201325","key":"1201_CR11","first-page":"e1","volume":"103","author":"CF Chapelle","year":"2015","unstructured":"Chapelle CF, Veersema S, Br\u00f6lmann HA, Jansen FW. Effectiveness and feasibility of hysteroscopic sterilization techniques: a systematic review and meta-analysis. Fertil Steril. 2015;103(1516\u201325):e1-3.","journal-title":"Fertil Steril"},{"key":"1201_CR12","unstructured":"Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Managing the Adnexae at the time of Hysterectomy for Benign Gynaecological Disease, 2014."},{"key":"1201_CR13","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 774: Opportunistic salpingectomy as a strategy for epithelial ovarian cancer prevention. Obstet Gynecol 2019;133:e279-e84.","DOI":"10.1097\/AOG.0000000000003164"},{"key":"1201_CR14","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jogc.2016.12.005","volume":"39","author":"S Salvador","year":"2017","unstructured":"Salvador S, Scott S, Francis J, Agrawal A, Giede C. No. 344-Opportunistic salpingectomy and other methods of risk reduction for ovarian\/fallopian tube\/peritoneal cancer in the general population. J Obst Gynaecol Can. 2017;39:480\u201393.","journal-title":"J Obst Gynaecol Can"},{"key":"1201_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/IGC.0b013e318199009c","volume":"19","author":"A Salvador","year":"2009","unstructured":"Salvador A, Gilks B, Kobel M, Huntsman D, Rosen B, Miller D. The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer. 2009;19:58\u201364.","journal-title":"Int J Gynecol Cancer"},{"key":"1201_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40661-015-0014-1","volume":"2","author":"GE Hanley","year":"2015","unstructured":"Hanley GE, McAlpine JN, Kwon JS, Mitchell G. Opportunistic salpingectomy for ovarian cancer prevention. Gynecol Oncol Res Pract. 2015;2:1\u201311.","journal-title":"Gynecol Oncol Res Pract"},{"key":"1201_CR17","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.jmig.2019.02.003","volume":"26","author":"AJ Kim","year":"2019","unstructured":"Kim AJ, Barberio A, Berens P, et al. The trend, feasibility, and safety of salpingectomy as a form of permanent sterilization. J Minim Invas Gynecol. 2019;26:1363\u20138.","journal-title":"J Minim Invas Gynecol"},{"key":"1201_CR18","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1097\/AOG.0000000000002312","volume":"130","author":"CB Powell","year":"2017","unstructured":"Powell CB, Alabaster A, Simmons S, et al. Salpingectomy for sterilization: change in practice in a large integrated health care system, 2011\u20132016. Obstet Gynecol. 2017;130:961\u20137.","journal-title":"Obstet Gynecol"},{"key":"1201_CR19","volume-title":"Canadian Cancer Statistics 2018","author":"Canadian Cancer Statistics Advisory Committee","year":"2018","unstructured":"Canadian Cancer Statistics Advisory Committee. Canadian Cancer Statistics 2018. Toronto: Canadian Cancer Society; 2018."},{"key":"1201_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ygyno.2017.05.034","volume":"146","author":"SE Dilley","year":"2017","unstructured":"Dilley SE, Havrilesky LJ, Bakkum-Gamez J, et al. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention. Gynecol Oncol. 2017;146:373\u20139.","journal-title":"Gynecol Oncol"},{"key":"1201_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/AOG.0000000000000630","volume":"125","author":"JS Kwon","year":"2015","unstructured":"Kwon JS, McAlpine JN, Hanley GE, et al. Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy. Obstet Gynecol. 2015;125:338\u201345.","journal-title":"Obstet Gynecol"},{"key":"1201_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ajog.2020.01.014","volume":"223","author":"A Ti","year":"2020","unstructured":"Ti A, Roe A, Whitehouse K, Smith R, Gaffield M, Curtis K. Effectiveness and safety of extending intrauterine device duration: a systematic review. Am J Obstet Gynecol. 2020;223:24-35.e3.","journal-title":"Am J Obstet Gynecol"},{"key":"1201_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2147\/PPA.S3464","volume":"2","author":"C Kailasam","year":"2008","unstructured":"Kailasam C, Cahill D. Review of the safety, efficacy and patient accepability of hte levonorgestrel-releasing intrauterine system. Pat Prefer Adherence. 2008;2:293\u2013302.","journal-title":"Pat Prefer Adherence"},{"key":"1201_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.contraception.2005.08.013","volume":"73","author":"K Van Houdenhoven","year":"2006","unstructured":"Van Houdenhoven K, van Kaam KJAF, van Grootheest AC, Salemans THB, Dunselman GAJ. Uterine perforation in women using a levonorgestrel-releasing intrauterine system. Contraception. 2006;73:257\u201360.","journal-title":"Contraception"},{"key":"1201_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ogrm.2017.09.002","volume":"27","author":"R McKay","year":"2017","unstructured":"McKay R, Schunmann C. Male and female sterilisation. Obstet Gynaecol Reprod Med. 2017;27:373\u20138.","journal-title":"Obstet Gynaecol Reprod Med"},{"key":"1201_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-019-0987-7","volume":"8","author":"R Gormley","year":"2019","unstructured":"Gormley R, Vickers B, Norman W. Comparing options for women seeking permanent contraception in high-resource countries: a protocol for a systematic review. Syst Rev. 2019;8:1\u20136.","journal-title":"Syst Rev"},{"key":"1201_CR27","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med"},{"key":"1201_CR28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman D, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1\u201334.","journal-title":"PLoS Med"},{"key":"1201_CR29","unstructured":"World Bank Group. World Bank Country and Lending Groups. 2019."},{"key":"1201_CR30","unstructured":"Wells G, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses., N.d."},{"key":"1201_CR31","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence\u2013study limitations (risk of bias). J Clin Epidemiol. 2011;64:407\u201315.","journal-title":"J Clin Epidemiol"},{"key":"1201_CR32","unstructured":"Ryan R. Cochrane Consumers and Comunication Review Group: data synthesis and analysis. In: Group. CCaCR, ed., 2013."},{"key":"1201_CR33","unstructured":"Popay J, Roberts H, Sowden A, et al. Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme Version 2006;1:b92."},{"key":"1201_CR34","doi-asserted-by":"publisher","first-page":"570.e1","DOI":"10.1016\/j.ajog.2017.07.011","volume":"127","author":"L Antoun","year":"2017","unstructured":"Antoun L, Smith P, Gupta JK, Clark TJ. The feasibility, safety, and effectiveness of hysteroscopic sterilization compared with laparoscopic sterilization. Am J Obstet Gynecol. 2017;127:570.e1-70.e6.","journal-title":"Am J Obstet Gynecol"},{"key":"1201_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1001\/jama.2017.21269","volume":"319","author":"K Bouillon","year":"2018","unstructured":"Bouillon K, Bertrand M, Bader G, Lucot J, Dray-Spira R, Zureik M. Association of hysteroscopic vs laparoscopic sterilization with procedural, gynecological, and medical outcomes. JAMA. 2018;319:375\u201387.","journal-title":"JAMA"},{"key":"1201_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejogrb.2014.04.043","volume":"180","author":"Fernandez H, Legendre G, Blein C, Lamarsalle L, Panel P","year":"2014","unstructured":"Fernandez H, Legendre G, Blein C, Lamarsalle L, Panel P. Tubal sterilization: pregnancy rates after hysteroscopic versus laparoscopic sterilization in France, 2006\u20132010. Eur J Obst Gynecol Reprod Biol. 2014;180:133\u20137.","journal-title":"Eur J Obst Gynecol Reprod Biol"},{"key":"1201_CR37","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1111\/1471-0528.14719","volume":"124","author":"E Jokinen","year":"2017","unstructured":"Jokinen E, Heino A, Karipohja T, Gissler M, Hurskainen R. Safety and effectiveness of female tubal sterilisation by hysteroscopy, laparoscopy, or laparotomy: a register based study. BJOG. 2017;124:1851\u20137.","journal-title":"BJOG"},{"key":"1201_CR38","doi-asserted-by":"publisher","first-page":"h5162","DOI":"10.1136\/bmj.h5162","volume":"351","author":"J Mao","year":"2015","unstructured":"Mao J, Pfeifer S, Schlegel P, Sedrakyan A. Safety and efficacy of hysteroscopic sterilization compared with laparoscopic sterilization: an observational cohort study. BMJ. 2015;351:h5162.","journal-title":"BMJ"},{"key":"1201_CR39","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/AOG.0000000000001615","volume":"128","author":"RB Perkins","year":"2016","unstructured":"Perkins RB, Morgan JR, Awosogba TP, Ramanadhan S, Paasche-Orlow MK. Gynecologic outcomes after hysteroscopic and laparoscopic sterilization procedures. Obstet Gynecol. 2016;128:843\u201352.","journal-title":"Obstet Gynecol"},{"key":"1201_CR40","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/pds.3766","volume":"24","author":"MM Conover","year":"2015","unstructured":"Conover MM, Howell JO, Wu JM, Kinlaw AC, Dasgupta N, Funk MJ. Incidence of opioid-managed pelvic pain after hysteroscopic sterilization versus laparoscopic sterilization, US 2005\u20132012. Pharmacoepidemiol Drug Saf. 2015;24:875\u201384.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1201_CR41","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.contraception.2017.12.015","volume":"97","author":"R Steward","year":"2018","unstructured":"Steward R, Carney P, Law A, Xie L, Wang Y, Yuce H. Long-term outcomes after elective sterilization procedures - a comparative retrospective cohort study of Medicaid patients. Contraception. 2018;97:482\u2013533.","journal-title":"Contraception"},{"key":"1201_CR42","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1067\/S0002-9378(03)00487-3","volume":"189","author":"F Carmona","year":"2003","unstructured":"Carmona F, Cristobal P, Casamitjana R, Balasch J. Effect of tubal sterilization on ovarian follicular reserve and function. Am J Obstet Gynecol. 2003;189:447\u201352.","journal-title":"Am J Obstet Gynecol"},{"key":"1201_CR43","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/bjc.2016.80","volume":"114","author":"K Gaitskell","year":"2016","unstructured":"Gaitskell K, Coffey K, Green J, et al. Tubal ligation and incidence of 26 site-specific cancers in the Million Women Study. Br J Cancer. 2016;114:1033\u20137.","journal-title":"Br J Cancer"},{"key":"1201_CR44","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2014.01.003","volume":"210","author":"JN McAlpine","year":"2014","unstructured":"McAlpine JN, Hanley GE, Woo MMM, et al. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention. Am J Obstet Gynecol. 2014;210:e1-11.","journal-title":"Am J Obstet Gynecol"},{"key":"1201_CR45","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ajog.2018.05.019","volume":"219","author":"GE Hanley","year":"2018","unstructured":"Hanley GE, Kwon JS, Finlayson S, Huntsman DG, Miller D, McAlpine JN. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada. Am J Obstet Gynecol. 2018;219:172.","journal-title":"Am J Obstet Gynecol"},{"key":"1201_CR46","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.fertnstert.2013.11.127","volume":"101","author":"E Malacova","year":"2014","unstructured":"Malacova E, Kemp A, Hart R, Jama-Alol K, Preen DB. Long-term risk of ectopic pregnancy varies by method of tubal sterilization: a whole-population study. Fertil Steril. 2014;101:728\u201334.","journal-title":"Fertil Steril"},{"key":"1201_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.14423\/SMJ.0000000000000779","volume":"111","author":"ML Zerden","year":"2018","unstructured":"Zerden ML, Castellano T, Doll KM, Stuart GS, Munoz MC, Boggess KA. Risk-reducing salpingectomy versus standard tubal sterilization: lessons from offering women options for interval sterilization. South Med J. 2018;111:173\u20137.","journal-title":"South Med J"},{"key":"1201_CR48","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.contraception.2017.02.017","volume":"95","author":"J Westberg","year":"2017","unstructured":"Westberg J, Scott F, Creinin MD. Safety outcomes of female sterilization by salpingectomy and tubal occlusion. Contraception. 2017;95:505\u20138.","journal-title":"Contraception"},{"key":"1201_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/dju410","volume":"107","author":"H Falconer","year":"2015","unstructured":"Falconer H, Yin L, Gronberg H, Altman D. Ovarian cancer risk after salpingectomy: a nationwide population-based study. JNCI J Natl Cancer Inst. 2015;107:1\u20139.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"1201_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/aogs.12516","volume":"94","author":"C Madsen","year":"2015","unstructured":"Madsen C, Baandrup L, Dehlendorff C, Kj\u00e6r SK. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nation-wide case-control study. Acta Obstet Gynecol Scand. 2015;94:86\u201394.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1201_CR51","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ygyno.2014.10.005","volume":"135","author":"CR Lessard-Anderson","year":"2014","unstructured":"Lessard-Anderson CR, Handlogten KS, Molitor RJ, et al. Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma. Gynecol Oncol. 2014;135:423\u20137.","journal-title":"Gynecol Oncol"},{"key":"1201_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/AOG.0000000000003092","volume":"133","author":"J Mao","year":"2019","unstructured":"Mao J, Guiahi M, Chudnoff S, Schlegel P, Pfeifer S, Sedrakyan A. Seven-Year outcomes after hysteroscopic and laparoscopic sterilizations. Obstet Gynecol. 2019;133:1.","journal-title":"Obstet Gynecol"},{"key":"1201_CR53","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1089\/jwh.2016.6035","volume":"26","author":"PI Carney","year":"2017","unstructured":"Carney PI, Yao J, Lin J, Law A. Comparison of Healthcare costs among commercially insured women in the United States who Underwent Hysteroscopis sterilization vs laparoscopic bilateral tubal ligation sterilization. J Women\u2019s Health. 2017;26:483\u201390.","journal-title":"J Women\u2019s Health"},{"key":"1201_CR54","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jmig.2005.05.016","volume":"12","author":"MD Levie","year":"2005","unstructured":"Levie MD, Chudnoff SG. Office hysteroscopic sterilization compared with laparoscopic sterilization: a critical cost analysis. J Minim Invasive Gynecol. 2005;12:318\u201322.","journal-title":"J Minim Invasive Gynecol"},{"key":"1201_CR55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jmig.2006.10.001","volume":"14","author":"MR Hopkins","year":"2007","unstructured":"Hopkins MR, Creedon DJ, Wagie AE, Williams AR, Famuyide AO. Retrospective cost analysis comparing Essure hysteroscopic sterilization and laparoscopic bilateral tubal coagulation. J Minim Invasive Gynecol. 2007;14:97\u2013102.","journal-title":"J Minim Invasive Gynecol"},{"key":"1201_CR56","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.contraception.2007.09.012","volume":"77","author":"DA Grimes","year":"2008","unstructured":"Grimes DA, Mishell DR Jr. Intrauterine contraception as an alternative to interval tubal sterilization. Contraception. 2008;77:6\u20139.","journal-title":"Contraception"},{"key":"1201_CR57","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.contraception.2007.01.002","volume":"75","author":"K Curtis","year":"2007","unstructured":"Curtis K, Marchbanks P, Peterson H. Neoplasia with use of intrauterine devices. Contraception. 2007;75:S60\u20139.","journal-title":"Contraception"},{"key":"1201_CR58","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/bjc.2015.89","volume":"112","author":"K Coffey","year":"2015","unstructured":"Coffey K, Beral V, Green J, Reeves G, Barnes I. Lifestyle and reproductive risk factors associated with anal cancer in women aged over 50 years. Br J Cancer. 2015;112:1568\u201374.","journal-title":"Br J Cancer"},{"key":"1201_CR59","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.contraception.2016.12.006","volume":"95","author":"PN Silva does Santas","year":"2017","unstructured":"Silva does Santas PN, Madden T, Omvig K, Peipert J. Changes in body composition in women using long-acting reversible contraception. Contraception. 2017;95:382\u20139.","journal-title":"Contraception"},{"key":"1201_CR60","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ajog.2020.09.011","volume":"224","author":"K Mills","year":"2021","unstructured":"Mills K, Marchand G, Sainz K, et al. Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis. Am J Obstet Gynecol. 2021;224:258-65.e4.","journal-title":"Am J Obstet Gynecol"},{"key":"1201_CR61","doi-asserted-by":"publisher","first-page":"221.e1","DOI":"10.1016\/j.ajog.2020.02.005","volume":"223","author":"GE Hanley","year":"2020","unstructured":"Hanley GE, Kwon JS, McAlpine JN, Huntsman DG, Finlayson SJ, Miller D. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada. Am J Obstet Gynecol. 2020;223:221.e1-21.e11.","journal-title":"Am J Obstet Gynecol"},{"key":"1201_CR62","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/AOG.0000000000000475","volume":"124","author":"T Madden","year":"2014","unstructured":"Madden T, McNicholas C, Zhao Q, Secura GM, Eisenberg DL, Peipert JF. Association of age and parity with intrauterine device expulsion. Obstet Gynecol. 2014;124:718\u201326.","journal-title":"Obstet Gynecol"},{"key":"1201_CR63","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijgo.2014.02.017","volume":"126","author":"J Youm","year":"2014","unstructured":"Youm J, Lee HJ, Kim SK, Kim H, Jee BC. Factors affecting the spontaneous expulsion of the levonorgestrel-releasing intrauterine system. Int J Gynecol Obstet. 2014;126:165\u20139.","journal-title":"Int J Gynecol Obstet"},{"key":"1201_CR64","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1471-0528.2000.tb13228.x","volume":"107","author":"T Backman","year":"2000","unstructured":"Backman T, Huhtala S, Blom T, Luoto R, Rauramo I, Koskenvuo M. Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users. BJOG. 2000;107:335\u20139.","journal-title":"BJOG"},{"key":"1201_CR65","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1111\/jog.13441","volume":"43","author":"NM Carvalho","year":"2017","unstructured":"Carvalho NM, Chou V, Modesto W, Margatho D, Garcia EA, Bahamondes L. User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey. Obst Genecol Res. 2017;43:1732\u20137.","journal-title":"Obst Genecol Res"},{"key":"1201_CR66","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3109\/13625180903203154","volume":"14","author":"T Romer","year":"2009","unstructured":"Romer T, Linsberger D. User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey. Eur J Contracept Reprod Health Care. 2009;14:391\u20138.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"1201_CR67","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.contraception.2007.09.006","volume":"77","author":"J Jensen","year":"2008","unstructured":"Jensen J, Nelson A, Costales A. Subject and clinician experience with the levonorgestrel-releasing intrauterine system. Contraception. 2008;77:22\u20139.","journal-title":"Contraception"},{"key":"1201_CR68","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ygyno.2018.02.006","volume":"149","author":"M Jareid","year":"2018","unstructured":"Jareid M, Thalabard J, Aarflot M, Bovelstad H, Lund E, Braaten T. Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study. Gynecol Oncol. 2018;149:127\u201332.","journal-title":"Gynecol Oncol"},{"key":"1201_CR69","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jogc.2017.06.038","volume":"40","author":"RWM Tai","year":"2018","unstructured":"Tai RWM, Choi SKY, Coyte PC. The cost-effectiveness of salpingectomies for family planning in the prevention of ovarian cancer. J Obstet Gynaecol Can. 2018;40:317\u201327.","journal-title":"J Obstet Gynaecol Can"}],"container-title":["Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-021-01201-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12978-021-01201-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-021-01201-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T18:30:31Z","timestamp":1672857031000},"score":1,"resource":{"primary":{"URL":"https:\/\/reproductive-health-journal.biomedcentral.com\/articles\/10.1186\/s12978-021-01201-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1201"],"URL":"https:\/\/doi.org\/10.1186\/s12978-021-01201-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-127845\/v1","asserted-by":"object"}]},"ISSN":["1742-4755"],"issn-type":[{"value":"1742-4755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,20]]},"assertion":[{"value":"10 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}